Compounds > tyrosine

tyrosine and Adenoma, Prostatic

tyrosine has been researched along with Adenoma, Prostatic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, DG; Merrimen, J; Rendon, R; Thomas, LN; Too, CK1
CAMERON, E; CAMPBELL, A1
Chicester, P; Conners, W; Johnson, A; Kogan, B; Legget, R; Levin, R; Lin, AD; Mannikarottu, A; Whitebeck, C1
Barni, T; Crescioli, C; Forti, G; Gulisano, M; Luconi, M; Maggie, M; Salerno, R; Serio, M; Vannelli, GB1
Bergmann, M1
Bobrzecka, K; Ostrowski, W; Rybarska, J1

Other Studies

6 other study(ies) available for tyrosine and Adenoma, Prostatic

ArticleYear
Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    The Prostate, 2015, Volume: 75, Issue:15

    Topics: Carboxypeptidases; Humans; Ki-67 Antigen; Male; Neoplasm Grading; Nitric Oxide Synthase Type III; Phosphorylation; Prolactin; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Receptors, Prolactin; Signal Transduction; STAT5 Transcription Factor; Testosterone; Tyrosine; Up-Regulation

2015
THE VALUE OF SEROMUCOID ESTIMATION IN THE MANAGEMENT OF PROSTATIC DISEASE.
    British journal of urology, 1964, Volume: 36

    Topics: Acid Phosphatase; Blood Chemical Analysis; Diagnosis, Differential; Humans; Male; Mucoproteins; Neoplasms; Orosomucoid; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Tyrosine

1964
L-NAME, a nitric oxide synthase inhibitor, diminishes oxidative damage in urinary bladder partial outlet obstruction.
    American journal of physiology. Renal physiology, 2006, Volume: 290, Issue:2

    Topics: Animals; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Prostatic Hyperplasia; Rabbits; Reperfusion Injury; Tyrosine; Urinary Bladder; Urinary Bladder Neck Obstruction

2006
Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:7

    Topics: Blotting, Western; Calcitriol; Calcium; Cell Death; Cell Division; Cholecalciferol; Electrophoresis, Polyacrylamide Gel; Fibroblast Growth Factor 10; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Growth Substances; Humans; Immunohistochemistry; Keratinocytes; Male; Microscopy, Electron; Phosphorylation; Primed In Situ Labeling; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Tyrosine

2000
[Use of POR 8 in urologic surgery].
    Zeitschrift fur Urologie und Nephrologie, 1972, Volume: 65, Issue:10

    Topics: Aged; Drug Combinations; Female; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Ornithine; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia; Tyrosine; Urinary Bladder; Urinary Bladder Neoplasms; Urologic Diseases; Vasopressins

1972
The effect of iodination on the activity and structure of acid phosphomonoesterase from human prostate.
    Acta biochimica Polonica, 1968, Volume: 15, Issue:4

    Topics: Acid Phosphatase; Binding Sites; Catechol Oxidase; Chemical Phenomena; Chemistry; Chlorides; Chromatography, Gel; Humans; Hydrogen-Ion Concentration; Iodine; Kinetics; Male; Prostate; Prostatic Hyperplasia; Spectrum Analysis; Tartrates; Tyrosine

1968